Clustering of CARMA1 through SH3–GUK domain interactions is required for its activation of NF-κB signalling

Hiromitsu Hara (), Tadashi Yokosuka, Hideki Hirakawa, Chitose Ishihara, Shinsuke Yasukawa, Masanori Yamazaki, Haruhiko Koseki, Hiroki Yoshida and Takashi Saito ()
Additional contact information
Hiromitsu Hara: Faculty of Medicine, Saga University
Tadashi Yokosuka: Laboratory for Cell Signaling, RIKEN Center for Integrative Medical Sciences
Hideki Hirakawa: Laboratory of Plant Genome Informatics, Kazusa DNA Research Institute
Chitose Ishihara: PRESTO, Japan Science and Technology Agency
Shinsuke Yasukawa: Graduate School of Medical Sciences, Kyushu University
Masanori Yamazaki: Faculty of Medicine, Saga University
Haruhiko Koseki: Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences
Hiroki Yoshida: Faculty of Medicine, Saga University
Takashi Saito: Laboratory for Cell Signaling, RIKEN Center for Integrative Medical Sciences

Nature Communications, 2015, vol. 6, issue 1, 1-12

Abstract: Abstract CARMA1-mediated NF-κB activation controls lymphocyte activation through antigen receptors and survival of some malignant lymphomas. CARMA1 clusters are formed on physiological receptor-mediated activation or by its oncogenic mutation in activated B-cell-diffuse large B-cell lymphomas (ABC-DLBCLs) with constitutive NF-κB activation. However, regulatory mechanisms and relevance of CARMA1 clusters in the NF-κB pathway are unclear. Here we show that SH3 and GUK domain interactions of CARMA1 link CARMA1 clustering to signal activation. SH3 and GUK domains of CARMA1 interact by either intra- or intermolecular mechanisms, which are required for activation-induced assembly of CARMA1. Disruption of these interactions abolishes the formation of CARMA1 microclusters at the immunological synapse, CARMA-regulated signal activation following antigen receptor stimulation as well as spontaneous CARMA1 clustering and NF-κB activation by the oncogenic CARMA1 mutation in ABC-DLBCLs. Thus, the SH3–GUK interactions that regulate CARMA1 cluster formations are promising therapeutic targets for ABC-DLBCLs.

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms6555 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms6555

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms6555

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().